New Funding Announcement from Blueberries Medical Corp.
In an exciting development for Blueberries Medical Corp., a prominent producer of medicinal cannabis in Latin America, the company has successfully orchestrated a non-brokered private placement aimed at raising C$1.05 million (approximately US$740,000). This new influx of capital comes from the sale of 96,064,935 common shares priced at C$0.011 each, expected to significantly bolster the company's operational capabilities and general working capital.
Leadership and Participation in the Offering
Notably, this offering will be spearheaded by Terraflos Inc., a well-regarded cannabis company operating across Latin America. Terraflos is led by Facundo Garreton, who holds multiple roles within Blueberries Medical as Chairman, CEO, and director. In addition, Guillermo Rodriguez, another key director within the company, is anticipated to be an active participant in the investment opportunity offered by this placement.
Understanding Related Party Transactions
The involvement of Terraflos and the aforementioned directors is classified as a "related party transaction" based on the provisions of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions. Consequently, Blueberries Medical will not be required to acquire a formal valuation or seek minority shareholder approval related to the insider participation, streamlining the investment process to facilitate quicker funding.
Strategic Use of Funds Raised
The capital raised through this offering is earmarked for crucial operational expansions and will significantly contribute to further developing the company’s general corporate infrastructure. Specifically, Blueberries Medical plans to enhance its production capabilities and explore further international distribution avenues, aligning its operational strategies with market demands.
Profile of Blueberries Medical Corp.
Blueberries Medical Corp. stands as a leader in the Latin American medicinal cannabis industry, cultivating and processing premium-quality cannabis derivatives. Its strategic base in the Bogotá Savannah of central Colombia allows for exceptional sourcing of cannabis products. With a dedicated team that possesses essential expertise in agriculture, pharmacology, and marketing, they are licensed for comprehensive operations that include cultivation, domestic distribution, and international export of both CBD and THC-based cannabis products.
Commitment to Quality and Expansion
Blueberries Medical’s commitment to scientific rigor, combined with its agricultural advantages, positions the company as an emerging global supplier, dedicated to producing standardized medicinal cannabis oil extracts. As the global market for these products expands, Blueberries is poised to capture significant market share, aided by its existing distribution networks and production capabilities.
Future Outlook
The recent funding initiative reflects Blueberries Medical's proactive approach toward capturing the growing demands within the medicinal cannabis market. The leadership is optimistic about expanding their cultivation capacities and leveraging their scientific expertise to meet the increasing demand for high-quality cannabis products. Furthermore, discussions around accessing new international markets continue, indicating a robust strategic intention behind the company's growth narrative.
Frequently Asked Questions
What is the purpose of the new funding from Blueberries Medical?
The funding will be used to enhance operational capabilities and to support general corporate and working capital needs.
Who is managing the new offering?
Terraflos Inc. will lead the new offering, with participation from its executives who are involved in Blueberries Medical.
What does the participation of insiders mean for the offering?
Insider participation is categorized as a related party transaction, which allows for a more streamlined process without requiring formal valuations.
Where is Blueberries Medical located?
The company operates primarily in central Colombia, specifically in the Bogotá Savannah region.
What products does Blueberries Medical produce?
Blueberries Medical produces premium-quality cannabis derivatives, focusing on both CBD and THC-based medical cannabis formulations.
